ArticleChembiochem : a European journal of chemical biology2026
A Bifunctional Protease Cleaves the Leader Peptide in the Biosynthesis of Class I Microviridins.
Article in Chembiochem : a European journal of chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microviridins are a prominent family of highly potent serine protease inhibitors, of which individual variants specifically inhibit different types of proteases of pharmacological interest. These natural products of cyanobacterial origin belong to the ribosomally synthesized and posttranslationally modified peptides and feature an unusual cage-like architecture, which is composed of characteristic lactone and lactam rings. While the modifying enzymes introducing the posttranslational modifications in the course of microviridin biosynthesis are well investigated, the removal of their N-terminal leader peptides by designated proteases-a key step during maturation-remains enigmatic. In this study, a bioinformatic approach led to the discovery of NosP, which was confirmed as the first specific protease involved in microviridin biosynthesis. In vitro assays with modified precursor peptide, which was obtained from in vitro pathway reconstruction, revealed that NosP is a bifunctional protease, with both endo- and aminopeptidase activities. These results, together with the finding that corresponding homologous leader peptides are widespread in cyanobacteria, may pave the way for the efficient production and bioengineering of class I microviridins in vivo and in vitro.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.